10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-017818`
Period End Date	20160331
Filing Date	20160505
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	rgnx-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 43 Cash Flow Statement 50

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.02M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$65.54M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$2.14M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$2.04M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$851.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.34M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.30M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.34M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.31M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$105.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$118.15M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$107.55M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$102.23M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.33M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$538.00K	USD	Point-in-time
Cost method investments	`CostMethodInvestments`	$300.00K	USD	Point-in-time
Cost method investments	`CostMethodInvestments`	$300.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$223.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$168.00K	USD	Point-in-time
Total assets	`Assets`	$214.98M	USD	Point-in-time
Total assets	`Assets`	$221.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$4.63M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$3.20M	USD	Point-in-time
Advance payments	`CustomerAdvancesCurrent`	$35.00K	USD	Point-in-time
Advance payments	`CustomerAdvancesCurrent`	$127.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.78M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$602.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$233.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.38M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2016; no shares authorized, issued and outstanding at December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2016; no shares authorized, issued and outstanding at December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2016 and December 31, 2015; 26,338 and 26,313 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2016 and December 31, 2015; 26,338 and 26,313 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$270.71M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$269.14M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$275.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-719.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.62M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-62.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$216.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$214.98M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$221.38M	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$328.00K	USD	1 Quarter
License revenue	`LicensesRevenue`	$100.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$59.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$104.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$440.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$6.00K	USD	1 Quarter
Total revenues	`Revenues`	$644.00K	USD	1 Quarter
Total revenues	`Revenues`	$393.00K	USD	1 Quarter
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$20.00K	USD	1 Quarter
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$66.00K	USD	1 Quarter
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$30.00K	USD	1 Quarter
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$33.00K	USD	1 Quarter
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$2.79M	USD	1 Quarter
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$6.18M	USD	1 Quarter
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$1.72M	USD	1 Quarter
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$5.48M	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-77.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$114.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$11.64M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.64M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.25M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$2.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$483.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$20.00K	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$483.00K	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-18.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.77M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$994.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$994.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.77M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.77M	USD	1 Quarter
Net decretion and dividends on convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$-755.00K	USD	1 Quarter
Net gain on extinguishment of convertible preferred stock	`NetGainOnExtinguishmentOfPreferredStockForEarningsPerShare`	$759.00K	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.77M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.50M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.94	USD	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.65M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.33M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.77M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$76.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.55M	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-471.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$48.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	-	USD	1 Quarter
Unrealized foreign currency transaction losses (gains)	`ForeignCurrencyTransactionGainLossUnrealized`	$-121.00K	USD	1 Quarter
Unrealized foreign currency transaction losses (gains)	`ForeignCurrencyTransactionGainLossUnrealized`	$13.00K	USD	1 Quarter
Imputed interest on related party promissory notes	`ImputedInterestOnRelatedPartyDebt`	$13.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-113.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-331.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$24.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$169.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$449.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$55.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$11.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$419.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-182.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$616.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.21M	USD	1 Quarter
Other related party payables	`IncreaseDecreaseInDueToOtherRelatedPartiesCurrent`	$795.00K	USD	1 Quarter
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-92.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$453.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.68M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.89M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$20.43M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.11M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$416.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$106.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-106.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-10.74M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$7.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$21.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$21.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$26.03M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-18.61M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$24.25M	USD	1 Quarter
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$25.37M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$25.37M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$35.51M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$7.00K	USD	1 Quarter
Conversion of related party promissory notes into Series C convertible preferred stock	`DebtConversionConvertedInstrumentAmount1`	$1.39M	USD	1 Quarter
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$422.00K	USD	1 Quarter
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$65.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.